Researchers Identified New Cellular Regulatory Mechanism

A study uncovered how RLIM modulates METTL14 to control RNA methylation during the cell cycle.

Updated on Oct. 6, 2026 in Life Sciences

Isometric editorial illustration of a complex molecular structure with geometric shapes, representing cell regulatory systems.
Researchers have identified a new cell-cycle-dependent mechanism regulating the METTL14 protein complex, offering critical insights into how cells maintain RNA methylation homeostasis. AI Illustration. Upload story photo >

Scientists have identified a cell-cycle-dependent ubiquitination mechanism of METTL14 that dictates RNA substrate engagement. This regulatory process plays a significant role in acute monocytic leukemia, offering new insights into how cells manage epitranscriptomic modifications.

Why it matters

The mechanism functions as a critical quality control process for epitranscriptomic mA regulation, which is essential for proper gene expression. By identifying this axis, researchers have clarified how cells maintain homeostasis through the controlled assembly of the METTL3-METTL14 complex.

The study utilized human RLIM-knockout cells and myeloid-specific Rlim-knockout mice to map the regulatory axis. The process involves K27-linked ubiquitin, which modulates complex assembly independently of protein stability.

The players

METTL14

This is a protein component of the METTL3-METTL14 methyltransferase complex that facilitates RNA methylation.

RLIM

RLIM is an E3 ubiquitin ligase that regulates the METTL14 complex through K27-linked ubiquitination.

The details

The regulatory cascade is initiated when CDK1 and cyclin B1 phosphorylate RLIM, which then triggers self-ubiquitination and proteasomal degradation. This dynamic allows transcriptome-wide mRNA mA levels and K27-ubiquitin intensity to oscillate in sync with the cell cycle.

Timeline

  1. The research findings were officially published on October 6, 2026.

The Big Picture

The discovery regarding METTL14 ubiquitination follows the established trajectory of the epitranscriptomics research initiative by linking RNA modification control to cell cycle progression.

This finding provides a new potential target for future therapeutic strategies in acute monocytic leukemia. By understanding the regulatory axis of mA methylation, researchers may eventually develop interventions that correct aberrant gene expression patterns in diseased cells.

The takeaway

This study highlights the intricate feedback loops that allow cells to coordinate complex protein assembly with the cell cycle. Researchers can use this framework to explore how disrupting specific ubiquitination signals impacts cellular health.

Further reading

Learn more about advancements in molecular genetics by visiting the Life Sciences section.

More information

Read the complete Nature Chemical Biology research article for detailed methodology.

Source note: This article includes information reported by Nature.